Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-24 9:21 pm Purchase | 2024-12-31 | 13G | Scinai Immunotherapeutics Ltd. SCNI | Stone Daniel E. | 87,746 9.990% | 25,346 (+40.62%) | Filing History |
| 2025-01-03 6:16 pm Sale | 2024-12-31 | 13G | BiondVax Pharmaceuticals Ltd. BVXV | SABBY MANAGEMENT LLC | 29,051 4.900% | -191,612 (-86.83%) | Filing History |
| 2024-11-14 4:28 pm Purchase | 2024-09-30 | 13G | Scinai Immunotherapeutics Ltd. SCNI | Armistice Capital, LLC | 44,800 4.990% | 44,800 (New Position) | Filing History |
| 2024-08-20 3:06 pm Purchase | 2024-08-19 | 13G | Scinai Immunotherapeutics Ltd. SCNI | Stone Daniel E. | 62,400 7.400% | 62,400 (New Position) | Filing History |
| 2024-03-12 4:17 pm Unchanged | 2024-03-12 | 13D | Scinai Immunotherapeutics Ltd. SCNI | Stone Daniel E. | 62,400 12.960% | 0 (Unchanged) | Filing History |
| 2024-02-14 3:53 pm Purchase | 2023-12-31 | 13G | Scinai Immunotherapeutics Ltd. SCNI | Armistice Capital, LLC | 51,832 9.990% | 51,832 (New Position) | Filing History |
| 2024-01-24 2:33 pm Purchase | 2023-12-31 | 13G | Scinai Immunotherapeutics Ltd. SCNI | Stone Daniel E. | 62,400 12.960% | 32,585 (+109.29%) | Filing History |
| 2024-01-02 4:54 pm Sale | 2023-12-31 | 13G | BiondVax Pharmaceuticals Ltd. BVXV | SABBY MANAGEMENT LLC | 220,663 11.000% | -7,666 (-3.36%) | Filing History |
| 2023-02-06 2:08 pm Purchase | 2022-12-31 | 13G | Scinai Immunotherapeutics Ltd. SCNI | Stone Daniel E. | 29,815 8.400% | 29,815 (New Position) | Filing History |
| 2023-01-04 09:21 am Purchase | 2022-12-31 | 13G | BiondVax Pharmaceuticals Ltd. BVXV | SABBY MANAGEMENT LLC | 228,329 11.000% | 228,329 (New Position) | Filing History |
| 2022-12-27 09:04 am Purchase | 2022-12-20 | 13D | BiondVax Pharmaceuticals Ltd. BVXV | NACHT MARIUS | 170,961,770 12.300% | 153,865,593 (+900.00%) | Filing History |
| 2022-10-06 10:23 am Purchase | 2022-09-19 | 13G | BiondVax Pharmaceuticals Ltd. BVXV | Stone Daniel E. | 3,748,852 5.020% | 3,748,852 (New Position) | Filing History |
| 2022-01-11 12:47 pm Unchanged | 2021-12-29 | 13D | BiondVax Pharmaceuticals Ltd. BVXV | NACHT MARIUS | 17,096,177 23.600% | 0 (Unchanged) | Filing History |
| 2021-02-09 06:01 am Unchanged | 2021-02-02 | 13D | BiondVax Pharmaceuticals Ltd. BVXV | NACHT MARIUS | 17,096,177 30.600% | 0 (Unchanged) | Filing History |